## partner-targets.md  
**Product:** `medic-verify` – Reliability‑validation platform for healthcare‑AI models  
**Goal:** Accelerate adoption by embedding `medic-verify` into the existing toolchains of AI‑enabled health tech companies, EHR vendors, and clinical‑research platforms.  

---  

### 1. Integration Roadmap (Quarterly)

| Quarter | Milestone | Partner(s) | Integration Type | Expected Impact |
|---------|-----------|------------|------------------|-----------------|
| **Q1 2026** | Core “validation‑as‑a‑service” API (REST + OpenAPI) | 1️⃣ **Google Cloud Healthcare API**  <br>2️⃣ **Microsoft Azure Health Data Services** | OAuth2 + FHIR‑based data ingestion | Gives immediate access to de‑identified patient datasets for model stress‑testing; opens channel to large cloud‑health customers. |
| **Q2 2026** | UI‑embedded “validation widget” for model‑dev portals | 3️⃣ **Weights & Biases (W&B)** <br>4️⃣ **Neptune.ai** | JavaScript SDK + webhook callbacks | Enables data‑scientists to launch `medic-verify` runs from their experiment tracking dashboards; drives organic usage among ML teams. |
| **Q3 2026** | Compliance & audit reporting add‑on | 5️⃣ **Veeva Vault QMS** <br>6️⃣ **Medidata Rave** | SAML SSO + PDF/JSON export API | Provides regulator‑ready audit trails (FDA 21 CFR 820, EU MDR) → high‑value for pharma‑clinical trial sponsors. |
| **Q4 2026** | Marketplace & revenue‑share launch | 7️⃣ **AWS Marketplace (Healthcare & Life Sciences)** <br>8️⃣ **Redox** (health‑data integration hub) | Marketplace listing + usage‑based billing; Redox HL7/FHIR connectors | Broad distribution to hospitals & health‑IT integrators; affiliate revenue share up to 20 % on billed usage. |

*Each quarter includes a 2‑week internal QA sprint, a 1‑week partner‑tech‑review, and a 1‑week joint‑marketing push (webinar, case‑study, co‑blog).*

---  

### 2. Partner Candidates (5‑8)  

| # | Partner | Core Service | Free‑Tier Limits (as of 2024‑2025) | Integration Effort* | Value‑Add (User Job Solved) | Affiliate / Rev‑Share Potential |
|---|---------|--------------|----------------------------------|----------------------|-----------------------------|---------------------------------|
| **1** | **Google Cloud Healthcare API** | FHIR, DICOM, HL7 data store | 1 TB storage, 10 M API calls/mo (free tier) | **M** – OAuth2 + FHIR mapping (existing SDKs) | Pull real‑world de‑identified patient cohorts for stress‑testing AI models. | Google Cloud Partner Program – up to **15 %** of incremental spend. |
| **2** | **Microsoft Azure Health Data Services** | FHIR server, consent management | 5 GB storage, 5 M API calls/mo | **M** – Azure AD auth + FHIR batch import | Same as #1, but taps Azure‑centric health ISVs. | Azure Marketplace revenue share **12 %**. |
| **3** | **Weights & Biases (W&B)** | Experiment tracking, model registry | 100 GB logged data, 10 M API calls/mo | **S** – JS SDK + webhook to trigger validation | One‑click “Validate” button inside W&B UI; reduces friction for data‑science teams. | Affiliate program – **10 %** of paid plan upgrades driven by our referral. |
| **4** | **Neptune.ai** | Model metadata & collaboration | 5 GB storage, 1 M API calls/mo | **S** – Similar to W&B, thin wrapper | Gives Neptune users built‑in reliability scores for each model version. | Referral fee **8 %**. |
| **5** | **Veeva Vault QMS** | Quality‑management & audit documentation | 1 GB docs, 5 k API calls/mo (sandbox) | **L** – SAML SSO + custom report generator | Auto‑generate FDA‑ready validation reports; saves compliance teams weeks of manual work. | Partner‑level rev‑share **15 %** on Vault add‑ons. |
| **6** | **Medidata Rave** | Clinical‑trial data capture | 10 GB data, 2 M API calls/mo (dev) | **L** – Complex HL7/FHIR mapping, secure enclave | Embeds validation into trial pipelines; ensures AI models used in trials meet reliability thresholds. | Revenue share **12 %** on per‑study licensing. |
| **7** | **AWS Marketplace (Healthcare & Life Sciences)** | SaaS distribution, billing | No free tier (pay‑as‑you‑go) | **M** – Package as container, publish via SAM | Gives hospitals & health‑tech firms a familiar procurement path; enables usage‑based billing. | AWS Marketplace takes **20 %** cut; we retain **80 %** of usage fees. |
| **8** | **Redox** | Health‑data integration hub (FHIR/HL7) | 100 k messages/mo, 1 GB data/mo | **M** – REST webhook + OAuth2 | Seamless ingestion of live EHR streams for continuous validation (drift detection). | Redox partner program – **10 %** of integration‑service fees. |

\*Effort rating: **S** = Small (≤1 week dev, existing SDK); **M** = Medium (1–3 weeks, custom mapping); **L** = Large (≥4 weeks, security review, compliance docs).

---  

### 3. Prioritisation Criteria  

| Criterion | Weight | Top Ranked Partners |
|-----------|--------|---------------------|
| **Revenue‑share potential** | 30 % | AWS Marketplace, Google Cloud, Veeva |
| **Strategic fit to healthcare AI** | 25 % | Azure Health Data, Redox, Medidata |
| **Ease of integration** | 20 % | W&B, Neptune, Google Cloud |
| **Free‑tier exposure (lead gen)** | 15 % | W&B, Neptune, Redox |
| **Regulatory compliance alignment** | 10 % | Veeva, Medidata |

**Resulting priority order:** 1️⃣ Google Cloud → 2️⃣ W&B → 3️⃣ Veeva → 4️⃣ Azure → 5️⃣ Redox → 6️⃣ Medidata → 7️⃣ Neptune → 8️⃣ AWS Marketplace (listed later for go‑to‑market scaling).  

---  

### 4. Next Steps (Action Items)

1. **Assign PM owners** – Q1: Cloud (Google/Azure), Q2: Experiment‑tracking (W&B/Neptune), Q3: Compliance (Veeva/Medidata), Q4: Marketplace (AWS/Redox).  
2. **Create integration spec docs** – use OpenAPI 3.0, include sample FHIR bundles and validation payload schemas.  
3. **Negotiate affiliate contracts** – target ≥ 12 % rev‑share where possible; prioritize partners with co‑marketing budgets.  
4. **Build sandbox environments** – spin up GCP & Azure health data sandboxes, W&B free org, Veeva dev tenant.  
5. **Launch joint webinars** – “Validating AI in Clinical Trials” (Medidata + Veeva) and “From Notebook to Regulated Model” (W&B + medic‑verify).  

---  

*Prepared by Business‑Synthesis – Q2 2026*